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A role for leptin and its cognate receptor in hematopoiesis
Brian D. Bennett*, Gregg P. Solar*, Jean Q. Yuan*, Joanne Mathias†,
G. Roger Thomas† and William Matthews*
Background: Hematopoiesis entails the production of multiple blood cell lineages
throughout the lifespan of the organism. This is accomplished by the regulated
expansion and differentiation of hematopoietic precursors that originate from self-
renewing hematopoietic stem cells. Studies of lineage commitment and
proliferation have shown that the cytokine family of growth factors plays an
important role in hematopoietic differentiation. However, in hematopoiesis, as in
most self-renewing biological systems, the molecules that regulate the stem cells
directly remain largely unknown. In this study, we have undertaken a search for
novel cytokines that may influence the fate of hematopoietic stem cells.
Results: We have cloned three splice variants of a novel cytokine receptor from
human hematopoietic stem cells expressing the CD34 antigen, one of which is
identical to the leptin receptor. Expression analysis revealed that the leptin receptor
is expressed in both human and murine hematopoietic stem cell populations, and
that leptin is expressed by hematopoietic stroma. We show that leptin provides a
proliferative signal in hematopoietic cells. Importantly, we demonstrate that leptin
provides a proliferative signal in BAF-3 cells and increases the proliferation of
hematopoietic stem cell populations. The proliferative effects of leptin seem to be
at the level of a multilineage progenitor, as shown by increased myelopoiesis,
erythropoiesis and lymphopoiesis. Analysis of db/db mice, in which the leptin
receptor is truncated, revealed that the steady-state levels of peripheral blood B
cells and CD4-expressing T cells were dramatically reduced, demonstrating that
the leptin pathway plays an essential role in lymphopoiesis. Colony assays
performed using marrow from db/db and wild-type mice indicated that db/db
marrow has a deficit in lymphopoietic progenitors; furthermore, db/db mice are
unable to fully recover the lymphopoietic population following irradiation insult, and
although the levels of peripheral blood erythrocytes are normal in db/db mice,
spleen erythrocyte production is severely compromized.
Conclusions: We have discovered that leptin and its cognate receptor constitute a
novel hematopoietic pathway that is required for normal lymphopoiesis. This
pathway seems to act at the level of the hematopoietic stem/progenitor cell, and
may well also impact upon erythropoiesis, particularly in anemic states that may
require output from the spleen. These findings offer a new perspective on the role
of the fat cell in hematopoiesis.
Background
Hematopoiesis is dependent upon the capacity of
hematopoietic stem cells to both replicate and generate an
extensive array of differentiated progeny. These tasks are
accomplished in vivo through complex interactions among
the cells that constitute the hematopoietic microenviron-
ment [1]. In the bone marrow, the principal hematopoietic
site in adult mammals, this microenvironment consists of a
heterogeneous network of cells that includes fibroblasts,
endothelial cells, macrophages, adipocytes, and mature
and immature hematopoietic cells. To date, an impressive
number of molecules with hematopoietic activity have
been discovered in this microenvironment [2]. However,
with the recent increase in cDNA sequences obtained
using expressed sequence tag (EST) approaches, it is pos-
sible that many others will be discovered. For example, no
molecules that specifically elicit the self renewal of
hematopoietic stem cells have been identified.
Many of the events involved in the development and
homeostasis of hematopoiesis — such as cell survival, pro-
liferation, differentiation and functional activation — can
be modulated by the cytokine family of growth factors [3].
Consequently, in our search for hematopoietic regulators
we sought to clone novel cytokine receptors that may be
involved in the proliferation of hematopoietic stem cells.
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This approach was based upon the structural similarity of
the cytokine receptors responsible for transducing biologi-
cal signals in hematopoietic cells. Notably, the members
of this family with predominantly hematopoietic expres-
sion — such as the interleukin receptors, the erythropoi-
etin receptor and the thrombopoietin receptor (c-mpl) —
have a structural unit in the extracellular region termed
the hemopoietin receptor domain. This domain contains
the distinctive signature motif Trp–Ser–X–Trp–Ser
(WSXWS; X denotes any amino acid) [4–6].
Using amino-acid sequences derived from the hemopoi-
etin receptor domain to probe the EST database, we
cloned a novel cytokine receptor bearing the distinctive
WSXWS motif from a CD34-expressing (CD34+) human
stem cell population. Interestingly, this receptor is identi-
cal to the recently cloned leptin receptor that is presumed
to transduce signals from the obese (ob) gene product, leptin
[7]. The same cytokine receptor has been cloned indepen-
dently from murine fetal liver and a yolk sac-derived cell
line, and shown to be expressed in primitive hematopoietic
cells [8]. Signal transduction through the leptin receptor
seems to be one of the major regulators of fat metabolism
in mammals, although the mechanism by which this is
accomplished is still unclear [7,9]. The expression of the
leptin receptor in CD34+ cells is intriguing, given the
spatial relationships often seen between cytokine producer
and responder cells. Initial results indicate that leptin is
made predominantly by fat cells (in both white and brown
adipose tissue) [10]. This is relevant to hematopoiesis
because, in humans, bone marrow adipocytes occupy most
of the marrow cavity [11]. However, despite being a major
component of the hematopoietic microenvironment, the
role of the fat cell in hematopoiesis has been difficult to
define.
A nurturing role for fat cells in hematopoiesis is supported
by several lines of evidence; marrow fat cells are preserved
during starvation [12,13], but depleted in states of induced
anemia [12,14]; the presence of mature adipocytes has
always been associated with murine long-term bone
marrow cultures that are hematopoietically active [15];
reticulum cells, the prospective progenitors for bone
marrow adipocytes, are active in granulopoiesis and lym-
phopoiesis; pre-adipocyte lines have also been shown to
maintain lymphopoiesis [15–18]; similarly, fat cells first
appear 7 days after irradiation of the marrow, and this has
been correlated with the onset of hematopoietic prolifera-
tion [19]. Nevertheless, it remains uncertain whether bone
marrow adipocytes play an active role in hematopoiesis, or
are only necessary from an architectural standpoint by pro-
viding structural support to the marrow [11,20].
In this article, we demonstrate a proliferative role for the
leptin signalling pathway in primitive hematopoietic cells.
Furthermore, analysis of the db/db mice, which only
express a truncated leptin receptor, underscores the impor-
tant role that leptin-mediated signal transduction plays in
lymphopoiesis.
Results
Identification of EST T73849
To identify novel cytokine receptors that may be active in
hematopoiesis, we carried out a homology search of the
EST database using amino-acid sequences of known
cytokine receptors. This identified a 416 bp EST (T73849)
with homology to human gp130. Within this region of
homology, T73849 putatively encodes the cytokine recep-
tor motif WSNWS. To obtain full-length cDNA clones,
oligonucleotide probes were designed from the EST
sequence and used to screen a human fetal liver library and
then a library from the hepatoma cell line Hep3B [21].
Sequence information from the resulting cDNAs allowed
the amplification of full-length clones from human CD34+
progenitor cells, using the RACE (rapid amplification of
cDNA ends) technique.
Three different cDNA clones were obtained from CD34+
cells (Fig. 1). The predicted sequence of the 4102 bp
cDNA clone 13.2 was identical to that of the leptin recep-
tor recently cloned by Tartaglia et al. [7]. Clone 13.2
includes an open reading frame of 1168 amino acids with
the hallmarks of a cytokine receptor. The two other clones
isolated from CD34+ cells appeared to represent splice
variants of the receptor, which differ in the cytoplasmic
domain following the lysine residue at position 891
(Lys891). Clone 6.4 stops five amino acids after Lys891 and
is the human homolog of the short form of the murine
receptor [9]. Clone 12.1 diverges from clones 13.2 and 6.4
after Lys891, and encodes a completely different cytoplas-
mic tail that lacks the putative Janus kinase (JAK)-binding
‘Box 2’ region found in clone 13.2 [5,22,23].
Expression analysis in stem cell populations
Many cytokine receptors are found to be expressed in
early cells of the hematopoietic lineage. Such receptors
and their cognate ligands form functional units that regu-
late the commitment and expansion of these progenitor
cells [2] To determine whether the leptin receptor has a
role in hematopoiesis, we examined its expression profile
in human and mouse stem cell populations. CD34+ cells
were isolated from human cord blood [24], and the long-
term repopulating murine fetal liver AA4+ Sca+ Kit+ stem
cell population (flASK cells) was isolated from midgesta-
tion fetal liver [25]. Both populations contain a heteroge-
neous mixture of hematopoietic stem cells and early
hematopoietic precursors. Analysis of these populations
using the polymerase chain reaction (PCR) showed that
mRNAs encoding all three forms of the receptor were
present in CD34+ cells (Fig. 2). We detected mRNAs for
the long and short forms of the receptor in flASK cells.
Thus far, we have not isolated from mouse tissues any
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cDNAs that encode the 12.1 cytoplasmic tail. Human B
cells isolated from peripheral blood using anti-
CD19/CD20 antibodies were also positive for mRNAs
expressing the short (6.4) and long (13.2) forms of the
receptor. Using oligonucleotide primers that specifically
corresponded to the leptin cDNA sequence, we showed
that the mRNA for this ligand was expressed in fetal liver
and fetal brain, as well as in two fetal liver stromal cell
lines, designated 10-6 and 7-4 (Fig. 2). Both of these
immortalized cell lines support myeloid and lymphoid
proliferation of stem cell populations [25].
The hematopoietic role of the leptin signalling pathway
Having established that leptin and its receptor were
expressed in the hematopoietic compartment, we sought
to characterize the potential hematopoietic role of this
transduction system. We initially designed antisense
oligonucleotides corresponding to several regions adjacent
to the initiation methionine of the leptin receptor. Using
these oligonucleotides, we performed methylcellulose
colony assays in the presence of complete conditioned
media containing serum, granulocyte/macrophage colony-
stimulating factor (GM-CSF), G-CSF, interleukin-3 (IL-
3), IL-6, erythropoietin (EPO) and c-Kit ligand (KL).
Under these conditions, the ability of human CD34+ stem
cells to form colonies was not inhibited: the number of
colonies per 103 cells formed in the presence of antisense
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Figure 1
Leptin receptor isoforms present in CD34+ stem cells from human
umbilical cord blood. Three splice variants of the leptin receptor were
isolated based on the original EST T73849. Clone 6.4 is the human
equivalent of the short form of the murine leptin receptor, Ob-Ra [9].
Clone 13.2 is the full-length human leptin receptor, and clone12.1 is a
novel form of the leptin receptor. A representation of the full-length
13.2 leptin receptor is shown above. Clone 13.2 contains the putative
JAK-binding domains, ‘Box 1’ and ‘Box 2’; the amino-acid sequence of
Box 2 is underlined. The splice variants arise after Lys891. ECD,
extracellular domain; TM, transmembrane domain.
ECD13.2 TM
Lys891
Box 1 Box 2
6.4 N888 F889 Q890 K891 RTDIL

12.1 N888 F889 Q890 K891 MLEGSMFVKSHHHSLISSTQGHK
HCGRPQGPLHRKTRDLCSLVYLL
TPPLLSYDPAKSPSVRNTQE

13.2 N888 F889 Q890 K891 PETFEHLFIKHTASVTCGPLLLEPETISEDI
SVDTSWKNKDEMMPTTVVSLLSTTDLEK
GSVCISDQFNSVNFSEAEGTEVTYEDES
QRQPFVKYATLISNSKPSETGEEQGLINS
SVTKCFSSKNSPLKDSFSNSSWEIEAQA
FFILSDQHPNIISPHLTFSEGLDELLKLEG
NFPEENNDKKSIYYLGVTSIKKRESGVLL
TDKSRVSCPFPAPCLFTDIRVLQDSCSHF
VENNINLGTSSKKTFASYMPQFQTCSTQ
THKIMENKMCDLTV
Figure 2
Expression profiles of (a) the leptin receptor
variants and (b) leptin in hematopoietic tissues.
Human CD34+ stem cells, murine flASK stem
cells, human CD19+/CD20+ B cells, and the
murine fetal liver stromal cell lines 7.4 and 10.6
were isolated, and mRNA was prepared as
described in Materials and methods. We
synthesized specific primers corresponding to
the nucleotide sequences of the human cDNA
clones 6.4, 13.2 and 12.1, the short and long
forms of the mouse leptin receptor (mLeptin-R)
and mouse leptin (mLeptin), and performed
PCR analysis as described in Materials and
methods. Primers specific for GAPDH were
used as controls. The specificity of the
amplified bands was confirmed by Southern
blot analysis (data not shown). The
oligonucleotide probes used for this analysis
were as follows: clone 6.4, a 47mer beginning
at nucleotide 2809; clones 12.1 and 13.2, a
28mer beginning at nucleotide 2838; murine
leptin receptor short and long forms, a 49mer
beginning at nucleotide 2671; murine leptin, a
49mer beginning at nucleotide 391. The leptin
receptor mRNA could not be amplified from the
stromal cell lines 10-6 and 7-4, and leptin
mRNA could not be amplified from the stem
cell populations (data not shown). For all cell
populations, control reactions were run in the
absence of reverse transcriptase, where no
specific amplification was observed.
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DNA was 323 ± 3, with sense DNA there were 287±5
colonies, and with oligonucleotides in which the sequence
was scrambled the number was 289 ± 7. However, when
these assays were performed in the presence of fetal calf
serum and either KL alone, or KL, IL-3 and IL-6, we
observed a significant inhibition of colony formation, par-
ticularly with the –20 antisense oligonucleotide (Fig. 3).
Similar results were obtained using flASK cells and appro-
priately designed oligonucleotides based on the sequence
of the mouse leptin receptor. The inhibitory effects of
antisense oligonucleotides in these experiments implies
the presence of leptin in the assay system. We could not
detect any mRNA for leptin within the stem cell popula-
tions that we used, and we consider fetal calf serum to be
the most likely source. The concentration of leptin in
bovine serum has not been reported but, for comparison,
very recent studies have indicated that human serum from
non-obese individuals contains ~5–10 ng ml–1 of leptin,
with levels reaching 50–100 ng ml–1 in obese states [26].
These results indicated that the leptin receptor transduces
a proliferative signal to the hematopoietic cell. We con-
firmed this hypothesis by analyzing thymidine incorpora-
tion in the IL-3-dependent cell line BAF-3. We first
carried out experiments in the absence of leptin by con-
structing fusion proteins [27] consisting of the extracellular
domain of the human growth hormone receptor (hGHR)
fused to the cytoplasmic domain of the leptin receptor
encoded by clone 13.2 or clone 12.1 (hGHR–hLeptin-
R13.2 and hGHR–hLeptin-R12.1, respectively). Transfec-
tion the BAF-3 cell line with plasmids encoding these
constructs allowed us to test thymidine incorporation fol-
lowing stimulation with hGH. These experiments showed
that hGHR–hLeptin-R13.2, but not hGHR–hLeptin-
R12.1, could trigger an increase in thymidine incorpora-
tion, which is a probable indication of a proliferative
response (Fig. 4a). These results were confirmed by using
leptin to stimulate thymidine incorporation in BAF-3 cells
transfected with the full-length 13.2 clone (Fig. 4b). Inter-
estingly, the expression of hGHR–hLeptin-R12.1 in BAF-
3 cells resulted in a decrease in the basal level of
thymidine incorporation when these cells were removed
from medium containing IL-3 (Fig. 4a). It is unclear what
the role of the 12.1 variant may be; further study is war-
ranted to determine if it has a role in the differentiation,
rather than proliferation, of hematopoietic cells.
To examine the hematopoietic activity of leptin, we
performed a variety of in vitro assays. In keeping with its
ability to transduce a proliferative signal in BAF-3 cells,
leptin stimulated a four-fold increase in the number  of
flASK cells grown in suspension culture in the presence of
25 ng ml–1 KL (Fig. 5a). Although the addition of KL at
this concentration was sufficient to permit modest expan-
sion of human stem cells, leptin alone was unable to effect
their survival. We tested a variety of hematopoietic growth
factors in suspension culture assays and found an apparent
synergistic effect of leptin on growth with KL, GM-CSF
and IL-3 (Table 1). We did not detect preferential expan-
sion of any particular lineage when the resulting cultures
were subjected to cytospin analysis. When methylcellulose
colony assays were carried out, leptin augmented myeloid
colony formation, and dramatically increased the formation
of lymphoid and erythroid colonies (Fig. 5b,c). Under
myeloid conditions, cytospin analysis revealed that 45 ± 7%
of the colonies were CFU–GM (colony-forming units–
granulocyte/macrophage), 48 ± 6% were CFU–Mixed, and
6 ± 1 % were BFU–E (burst-forming units–erythrocytes).
Figure 3
Antisense oligonucleotides based on the sequence of the leptin
receptor inhibit colony formation in stem cell populations. Human
CD34+ stem cells and murine flASK cells were isolated as described
in Materials and methods. Methylcellulose assays were performed
using sense and antisense oligonucleotides that corresponded to the
cDNA sequence of the leptin receptor, starting at position –20 and
+85 with respect to the initiation methionine codon; see Materials and
methods for details. Sense and scrambled oligonucleotides were used
as controls. The number of colonies formed per 103 cells was
assessed after 14 days in culture. Assays were performed in
quadruplicate and the results confirmed in three independent
experiments.
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Table 1
Growth factor-induced proliferation of flASK cells.
Factor KL KL + leptin Leptin
N/A 128 ± 9 192 ± 13
G-CSF 131 ± 3 177 ± 8 30 ± 5
GM-CSF 148 ± 4 165 ± 6 134 ± 10
IL-3 189 ± 7 187 ± 4 144 ± 10
IL-6 112 ± 4 198 ± 5 32 ± 3
EPO 121 ± 3 177 ± 8 30 ± 6
IL-3 + IL-6 112 ± 2 198 ± 7 32 ± 7
Cells (2 × 105) were plated in suspension culture with the relevant
growth factor combination. Cells were harvested and counted after
5 days. Cell numbers × 103 are shown. Assays were performed in
triplicate and repeated in two independent experiments. N/A, no
addition. Note that 100 ng ml–1 KL was added to these cultures.
The presence of leptin in the myeloid methylcellulose cul-
tures did not give rise to any significant differences in the
resulting phenotypes. Importantly, the hematopoietic
activity of leptin was not confined to fetal liver stem
cells — the mouse bone marrow Linlo Sca+ stem cell popu-
lation also proliferated in response to leptin (KL, 5-fold
expansion; KL and leptin, 10-fold expansion).
Analysis of hematopoiesis in db/db mice
Further hematopoietic analysis of the role of the leptin
receptor was facilitated by the recent cloning of the
mouse db gene [9,28]. Previous data had suggested that
the db gene encodes the leptin receptor [29,30]. It has
been confirmed very recently that db/db mice express a
truncated splice variant of the leptin receptor, which
probably renders it defective in signal transduction [9,28].
We initially examined the hematopoietic defects in this
mouse by measuring the proliferative potential of db/db
homozygous mutant marrow. Under conditions favoring
either myeloid [31] or lymphoid expansion [32], the
colony-forming potential of the db/db marrow was signifi-
cantly reduced compared to the wild-type control marrow
(Fig. 6). This was particularly evident when the compari-
son was made under pre-B (lymphoid) methylcellulose
conditions, where KL and IL-7 were used to drive lym-
phopoiesis (Fig. 6). Similar analysis of marrow from ob/ob
mice, which are deficient in the production of leptin [33],
also indicated that the lymphoproliferative capacity was
compromized in the absence of a functional leptin
signalling pathway (Fig. 6). However, this reduction was
less than that observed with db/db marrow.
Analysis of the cellular profile of the db/db and wild-type
marrow revealed significant differences between the two.
The total number of cells in the db/db marrow was
unchanged (data not shown), but when we examined
various B-cell populations in the db/db marrow, we found
decreased levels of B220+ and B220+ CD43+ cells. B220+
cells represent all B-cell lineages, whereas CD43 is
thought to be expressed preferentially on the earliest cells
of the B-cell hierarchy [34]. The anti-CD43 antibody rec-
ognizes leukosialin [35], a major sialoglycoprotein on
myeloid and T lymphocytes, as well as B-lineage cells. It
is interesting that the CD43+ population in the heterozy-
gous db/misty gray mouse was increased, but the implica-
tions of this are unclear. We found no differences between
the CD4 and CD8 staining profiles of the two groups.
Interestingly, the TER 119 (a red cell lineage marker)
population was increased in the db/db marrow (Fig. 7a).
The spleens of db/db mice showed a significant decrease in
tissue weight and in the number of cells compared with the
homozygous misty gray controls (37 ± 6 mg versus
63 ± 9 mg; 4.3 × 107 ± 1 × 104 cells versus 1.10 × 108 ± 1 × 105
cells: p > 0.05). The decrease in the number of cells in the
db/db spleen was reflected by a marked reduction in
TER 119 staining (Fig. 7b). This result seems to confirm
that leptin and EPO act synergistically, and points to a role
for leptin in the regulation of erythropoiesis.
Examination of the hematopoietic compartments of db/db
mice revealed that the number of peripheral blood lym-
phocytes was significantly reduced compared with het-
erozygous or wild-type controls (Fig. 8). Because db/db
mice fail to regulate blood glucose levels and become dia-
betic at approximately 6–8 weeks of age, we followed
peripheral blood counts as the animals matured. This
analysis demonstrated that the number of peripheral
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Figure 4
Thymidine incorporation assays using leptin receptor variants in BAF-3
cells. (a) hGHR–hLeptin-R12.1 or hGHR–hLeptin-R13.2 fusion
proteins were expressed in BAF-3 cells as described in Materials and
methods. These transfected cells and the parental BAF-3 line were
stimulated with hGH, and the incorporation of tritiated thymidine was
determined. (b) BAF-3 cells were stably transfected with the cDNA
encoding hLeptin-R13.2; thymidine incorporation was then determined
in these cell lines following stimulation with human leptin. Assays were
performed in triplicate and the results were confirmed in three
independent experiments.
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blood lymphocytes was significantly reduced at all time
points compared with control animals, and that the periph-
eral lymphocyte population in db/db mice does not change
significantly with age or with the onset of diabetes (Fig.
8). FACS analysis revealed that the decrease in the lym-
phocyte population resulted from a decline in the number
of B220+, CD4+ and CD8+ cells; the number of erythro-
cytes and platelets were at wild-type levels throughout all
time periods examined. Interestingly, the number of
peripheral blood lymphocytes in ob/ob homozygous
mutant mice was the same as in the wild-type controls,
suggesting that a compensatory mechanism operates in
ob/ob mice, but not in db/db mice. The difference in the
number of lymphocytes may be attributable to the differ-
ent background strains of the ob/ob and db/db mice, or it
may result from the presence of a locally acting alternative
ligand for the leptin receptor.
Because hematopoietic analysis of db/db mice can be
complicated by the onset of diabetes, we examined the
impact of high glucose levels on lymphopoiesis by com-
paring the peripheral blood profiles and blood glucose
levels in db/db (and control) mice and in two other diabetic
models — glucokinase heterozygous knockout mice [36]
and IFN-a transgenic mice [37]. The results showed that
there was no relationship between blood glucose levels
and peripheral lymphocyte counts (Fig. 9). These data
therefore suggest that the lymphoid defects seen in db/db
mice are directly attributable to the hematopoietic func-
tion of the leptin signalling pathway. However, at this
time we cannot rule out secondary events that may result
from the eventual diabetic state of the db/db mouse.
To test the ability of the db/db hematopoietic compartment
to respond to challenge, we subjected db/db mice and con-
trols to a sub-lethal dose of g irradiation (Fig. 10). The
kinetics of hematopoietic recovery were then followed by
Figure 6
Methylcellulose assays to determine the colony-forming potential of
db/db, ob/ob, and the corresponding wild-type marrow. Bone marrow
cells (1 × 105) were seeded into methylcellulose, and the resulting
colonies were counted after 14 days. Assays were performed in
triplicate under myeloid and lymphoid conditions, and the experiments
were repeated a minimum of three times. Differences between db/db
and wild-type mice under both culture conditions, and ob/ob and
wild-type mice under lymphoid conditions were statistically
significant: p > 0.05.
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(c)
Expansion of murine flASK stem cells in suspension or
methylcellulose culture. (a) flASK cells were cultured in liquid medium
containing serum, and either 25 ng ml—1 KL, or KL and leptin. Cell
counts and cytospin analyses were performed 5 days later. (b) flASK
cells were seeded into methylcellulose under myeloid or lymphoid
conditions, as described in Materials and methods. Colony counts
were performed 14 days later. For colonies produced under lymphoid
conditions, FACS (fluorescence-activated cell sorting) analysis
showed that the vast majority of cells were B220+. (c) flASK cells
were seeded into methylcellulose containing KL; EPO, or EPO and
leptin, were then added to this basic medium. The resulting colonies
were counted 14 days later. FACS analysis showed that
approximately 95 % of these colonies were TER 119+. All assays
were performed in triplicate and confirmed in at least three
independent experiments. All stimulations by leptin were statistically
significant: p > 0.05.
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monitoring the peripheral blood during the recovery phase.
This illustrated the inability of the db/db hematopoietic
system to fully recover the lymphopoietic compartment of
the peripheral blood 35 days after irradiation. Platelet
levels in these mice followed the same recovery kinetics as
controls; however, the reduction in the number of erythro-
cytes in db/db mice lagged behind controls by 7–10 days.
The increased TER 119+ population found in the db/db
marrow may explain this intriguing finding (Fig. 7a).
Discussion
We have isolated a novel cytokine receptor — based upon
its homology with gp130 — that is expressed in human
CD34+ cells and murine flASK cells. This receptor was
found to be identical to the leptin receptor, which was
expression cloned using the ob gene product, leptin [7,29].
It is thought that the primary physiological role of leptin is
to control body weight; this is presumably mediated, at
least in part, by signal transduction through the leptin
receptor in the hypothalamus [7,9]. However, in keeping
with many other cytokines, we show that the leptin sig-
nalling pathway also has a role in hematopoiesis. As with
other cytokine receptors, the leptin receptor seems to be
expressed on progenitor and more mature hematopoietic
cells. However, the proliferative effect of leptin on
hematopoietic stem cell populations in myeloid, lymphoid
and erythroid colony assays demonstrates that leptin can
act on very early cells of the hematopoietic lineage. Anti-
sense oligonucleotide experiments, using both human and
mouse stem cell populations, demonstrated an inhibition
Figure 8
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Figure 7
Bone marrow cellular profiles in wild-type
misty gray homozygotes, db/misty gray
heterozygotes, and db/db homozygotes. The
overall number of cells in the db/db marrow
was unchanged compared to controls. (a)
Cellular profiles were determined using anti-
B220, anti-CD43 (clone S-7), and anti-
TER 119 antibodies. (b) Cellular profiles of
the spleens from the above groups.
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of myeloid colony formation, although the reduction in
myelopoiesis could be prevented by the additional inclu-
sion of G-CSF and GM-CSF in the culture medium.
These data serve to illustrate the compensatory capacity
of cytokine action in the myelopoietic compartment.
Although the myeloid growth-promoting aspects of leptin
signalling appear to be redundant, the effects upon lym-
phopoiesis seem to be more influential. Hematopoietic
analysis of db/db mice revealed an inherent deficit in
lymphopoiesis. In accordance with the proliferative activ-
ity of leptin on stem cell populations, this deficit seems to
extend to the pro-B cell stage, as indicated by the reduc-
tion in B220+ CD43+ cells in the db/db marrow. Impaired
lymphopoiesis is further illustrated by the reduced levels
of lymphocytes in the peripheral blood, and the inability
of this component to fully recover following irradiation.
Our analysis of various models with high blood glucose
levels showed no correlation between blood glucose levels
and the number of peripheral lymphocytes. This argues
strongly that the lymphocyte deficit in db/db mice is not a
result of the ensuing diabetic state. However, we are
further addressing this issue in transplant models of db/db
marrow, in both wild-type and scid mice. Engraftment into
scid mice should allow us to determine the impact of a
non-functional leptin receptor to immune challenge. 
The role of leptin and its receptor in erythropoiesis
warrants further study. Leptin acts synergistically with
EPO and KL to increase erythroid colony production,
indicating again that it acts at the level of the progenitor
cell. However, analysis of db/db mice revealed no periph-
eral defect in erythropoiesis. Interestingly, the db/db
spleen shows a dramatic reduction in the number of cells
expressing the erythrocytic lineage-specific marker
TER 119, while the number of TER 119+ cells in the
marrow is almost doubled compared to wild-type controls.
In the adult mouse, the spleen contributes to normal ery-
thropoiesis, so it is conceivable that the increased number
of TER 119+ cells in the marrow reflects a compensatory
mechanism for decreased splenic output. The increased
TER 119+ population in the marrow may also explain the
decreased susceptibility of db/db erythrocytes to radiation.
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Recovery kinetics of levels of (a) peripheral blood lymphocytes, (b)
erythrocytes and (c) platelets in misty gray homozygotes, db/misty gray
heterozygotes, and homozygous db/db mice subjected to a sub-lethal
dose of g irradiation. Peripheral blood samples were obtained via retro-
orbital bleeds, as described in Materials and methods.
Figure 9
Comparison of peripheral blood lymphocyte counts and blood glucose
levels in misty gray, db/misty gray, db/db, interferon-a transgenic, and
glucokinase heterozygous knockout mice. Blood samples were taken
from the orbital sinus and glucose levels were determined as
described in Materials and methods. Areas described by the boxes
represent the mean ± one standard deviation of the two parameters.
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Having defined a role for the leptin signalling pathway in
the expansion of primitive hematopoietic cells, what are the
implications of the presence of fat cells in the hematopoi-
etic microenvironment? From the mRNA expression data
presented here, it seems probable that leptin can be pro-
duced by hematopoietic stromal cells, as well as by
extramedullary fat cells. It is presumed, although not
proven, that the marrow adipocyte is stromal in origin.
Hence, the relationship between stromal cells and bone
marrow adipocytes in the production of leptin may hold the
key to understanding the role of the marrow adipocyte in
hematopoiesis. It is possible that the inverse relationship
between hematopoietic activity and the number of lipid-
containing cells seen under certain long-term culture condi-
tions [11,20] is attributable to changes in leptin production
upon differentiation of marrow stroma to adipocytes. It is is
not yet known whether marrow fat cells can produce leptin,
but it is tempting to speculate that the impressive fat cell
content of human marrow reflects the requirement for
leptin in active hematopoiesis, especially lymphopoiesis.
The findings presented here also have implications for a
variety of leukemic states  in which the role of the fat cell
has also been difficult to define. For example, it has been
reported that stroma from patients with chronic myeloid
leukemia has a reduced capacity to produce fat cells [38],
and several reports have indicated reduced fat content in
leukemic patients [38–40]. Spontaneous fat cell formation
has also been speculated to characterize patients who most
readily engraft following bone marrow transplantation [38].
Clearly, the role of the intramedullary fat cell will attract
much greater attention now that a mechanistic reason for
their existence can be considered.
Conclusions
These findings clearly demonstrate a role for leptin
signalling in mammalian hematopoiesis, and show that
leptin can act at the level of the hematopoietic progenitor to
stimulate multilineage expansion. Furthermore, analysis of
db/db mice indicates that this signalling pathway plays an
important role in maintaining the lymphopoietic compo-
nent of the peripheral blood. These data also suggest a role
for leptin in erythropoiesis, where synergy between leptin
and erythropoietin is evident. Compensatory mechanisms
in the bone marrow of db/db mice obviate peripheral
anemia, but in the spleen, an important site of erythrocyte
production in the mouse, leptin signalling seems to be a
constitutive component of erythropoiesis. Previous data
have indicated that adipocytes are the major source of
leptin; our findings will therefore help to determine the role
of the bone marrow adipocyte in hemotopoiesis.
Materials and methods
Isolation of hematopoietic stem cell populations
Human CD34+ stem cells were isolated from human umbilical cord blood
as previously described [24]. Murine fetal liver flASK stem cells were iso-
lated from the midgestational fetal liver as previously described [25].
Stem cell suspension cultures
Stem cells were isolated as above. Cells (2 × 106) were seeded in
individual wells in 12-well plates in DMEM 4.5/F12 media supplemented
with 10 % heat-inactivated fetal calf serum (FCS; Hyclone, Logan, Utah)
and L-glutamine. Growth factors were added at the following concentra-
tions: KL, 25 ng ml–1; IL-3, 25 ng ml–1; IL-6, 50 ng ml–1; G-CSF,
100 ng ml–1; EPO, 2 U ml–1; IL-7, 100 ng ml–1 (all growth factors were
from R and D Systems, Minneapolis, Minnesota). Leptin was added at
100 ng ml–1 unless indicated otherwise. Recombinant leptin was pro-
duced as described [41]. Briefly, mature leptin was expressed in
Escherichia coli by inserting the leptin coding sequence in frame with the
sequence encoding the signal for the secretion of the E. coli heat-stable
enderotoxin II, downstream of the E. coli alkaline phosphatase promoter.
After cell lysis, the insoluble fraction was solubilized in 8 M urea buffer
(pH 8.35) containing 25 mM dithiothreitol. Reduced leptin was purified
by size exclusion and reverse-phase HPLC, and refolded in the presence
of glutathione. Refolded leptin was purified by reverse-phase HPLC and
subjected to SDS–PAGE, amino-acid and mass spectroscopic analyses.
Methylcelluose colony assays
Methylcellulose assays were performed as previously described [25],
using ‘complete’ methylcellulose or pre-B methylcellulose medium
(Stem Cell Technologies, Vancouver, British Columbia) with the addi-
tion of 25 ng ml–1 KL (R and D Systems). Cytospin analyses of the
resulting colonies were performed as previously described [25]. For
cells plated under lymphoid or erythroid conditions, colonies were har-
vested, washed in Hank’s balanced salt solution (HBSS) containing
2 % FCS and pooled at a concentration of 5 × 106 per ml. 1 × 106 cells
were used for each sample and stained using antibodies directed
against B220 or TER 119, or appropriate controls.
Tissue harvest and FACS analysis
Bone marrow, spleens and peripheral blood were harvested from the dia-
betic mouse strains C57BLKS/J db/db (mutant), C57BLKS/J m+/db
(lean heterozygous control littermate) and C57BLKS/J+m/+m (lean
homozygote misty gray coat control littermate), and the obese mouse
strains C57BL/6J-ob/ob (mutant) and C57BL/6J-ob/+ (lean littermate
control). All strains were from the Jackson Laboratory, Bar Harbor, Maine.
A minimum of five animals were used per experimental group. Femurs
were flushed with HBSS containing 2 % FCS and a single cell suspen-
sion was made of the bone marrow cells. Spleens were harvested and
the splenic capsule was ruptured and filtered through a nylon mesh.
Peripheral blood was collected through the retro-orbital sinus in phos-
phate buffered saline (PBS) containing 10 U ml–1 heparin and 1 mmol
EDTA. The bone marrow, splenocytes and peripheral blood were then
stained with monoclonal antibodies directed against the following mouse
antigens: B220/CD45R (FITC), TER 119 (R-PE), CD4/L3T4 (FITC),
CD8/Ly2,3 (FITC), and CD43 (R-PE); antibodies were conjugated to
FITC (fluorescein isothiocyanate) or R-PE (R-phycoerythin), as indicated.
All monoclonal antibodies were from Pharmigen, San Diego, California.
The appropriate isotype controls were included in each experiment. For
methylcellulose colony assays, the bone marrow from five animals in each
group was pooled and 1 × 105 cells used for each assay point.
Searching the dbEST database 
Protein sequence files for the cytokine receptors IL-6R, IL-3R, LIFR, c-
mpl, gp130, IL11-R and GM-CSFR were used to search the dbEST
database [42] using the basic local alignment search tool (BLAST) [43].
Cloning of the full-length receptor 
We synthesized an oligonucleotide probe, designated WSX.6#1, that
was based on the T73849 EST sequence. The WSX.6#1 probe was a
51mer with the following sequence: 5′–GTCAGTCTCCCAGTTCCA-
GACTTGTGTGCAGTGCAGTCTATGCTGTTCAGGTGCGC–3′. The
radiolabeled WSX.6#1 DNA was used to probe 1.2 × 106 clones from
a random and oligo dT-primed lgt10 fetal liver library (Clontech, Palo
Alto, California). From the initial screen, five individual plaque pure
clones were isolated.
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To obtain the full-length genes, clone 6.4 (Nsi–HindIII fragment) was
radiolabeled and used to screen 1.2 × 106 clones from a lgt10 library
constructed from a hepatoma Hep3B cell line. This screen resulted in
the isolation of 12 independent clones, but it was unclear which clones
contained the correct 3′ end of the molecule. We therefore performed
3′ RACE using CD34+ human hematopoietic stem cells. Briefly, poly
A+ RNA was isolated from ∼106 CD34+ hematopoietic stem cells
using the FastTrack method for mRNA isolation (Invitrogen, San Diego,
California). Double-stranded cDNA synthesis and subsequent 3′ RACE
was performed with the Marathon cDNA Amplification Kit (Clontech)
following manufacturer’s protocols. 3′ RACE products were generated
using a forward hLeptin-R specific primer, corresponding to
nucleotides 2534–2563, and a 3′ anchored reverse primer provided by
the manufacturer. DNA sequencing was performed with the Taq dye
deoxynucleotide terminator cycle sequencing kit on an automated
Applied Biosystems DNA sequencer.
Construction of hGHR–hLeptin-R fusion proteins
Recombinant PCR was used to generate the chimeric receptors
containing the extracellular and transmembrane domains of the hGHR
and the cytoplasmic domain of either hLeptin-R12.1 or hLeptin-R13.2.
In short, the cytoplasmic domain of clone 12.1 or 13.2 beginning with
Arg at residue 866 and extending down to residue 958 or residue
1165, respectively, was fused in frame, by sequential PCR, to the
hGHR extracellular and transmembrane domain beginning with Met18
and extending down to Arg274.
RNA isolation and reverse-transcription PCR analysis 
All RNAs were isolated using the FastTrack method (Invitrogen). For
tissues and cell lines, mRNA was isolated from either 1 g of tissue or
108 cells. For cell populations ∼3 × 105 cells were used. cDNA was
synthesized with Superscript II reverse transcriptase (BRL/Gibco,
Bethesda, Maryland), using either oligo dT or random hexamer priming.
Reverse-transcription PCR (RT–PCR) reactions from fetal liver, fetal
brain, and 7.4 and 10.6 cells were performed using 20 ng of poly A+
mRNA. RT–PCR from cell populations was performed with ∼1–3 × 104
cell equivalents per reaction; 1/5th of the reaction was used for gel
analysis. PCR was performed for 40 cycles of amplification with 97 °C
denaturation for 20 sec, 60 °C hybridization for 30 sec, and 72 °C
extensions for 1 min. Reactions containing no reverse transcriptase
were run for each RT–PCR reaction to demonstrate absence of
genomic DNA contamination. To further insure against genomic DNA
contribution, the primers for the leptin receptor were designed to span
the splice/donor acceptor site at Lys891. For the leptin molecule we
designed primers to span the splice/donor acceptor site at Gln201, the
splice site of the 2G7 clone produced by exon trapping [33].
Oligonucleotide primers (F, forward; R, reverse) used for RT–PCR
expression analysis were as follows:
hLeptin-R13.2; 13.2F 5′–GAAGATGTTCCGAACCCCAAGAATTG–3′
(nucleotides 2810–2835); 13.2R; 5′–CTAGAGAAGCACTIGGT-
GACTGAAC–3′ (nucleotides 3213–3237).
hLeptin-R6.4; 6.4F 5′CCATTGAGAAGTACCAGTTCAGTCTTTACC-
3′ (nucleotides 2601–2630); 6.4R; 5′–GGGAAGTTGGCA-
CATTGGGTTCA–3′ (nucleotides 2908–2930).
hLeptin-R12.1; 13.2F 5′–GAAGATGTTCCGAACCCCAAGAATTG–3′
(nucleotides 2810–2835); 12.1R 5′–GGATTTGGCAGGGTCATAG-
GACAA–3′ (nucleotides 3019–3043).
mLeptin-R (short form); muLep-RaF 5′–ATGCTATCGACAA-
GAATTG–3′ (nucleotides 2546–2570); mLeptin-RaR 5′–AGT-
CATTCAAACCATAGTTAGG–3′ (nucleotides 2843–2865).
mLeptin-R (long-form); muLep-RbF 5′–ACACTGTTAATTTCACACCA-
GAG–3′ (nucleotides 2629–2651); muLep-RbR 5′–TGGATAAACC-
CTTGCTCTTCA–3′ (nucleotides 3054–3074).
mLeptin; mObLF 5′–AGTGCCTATCCAGAAAGTCCAGGA–3′
(nucleotides 118–142; mObLR 5′–CTGTTGAAGAATGTCCTGCA-
GAGA–3′ (nucleotides 513–536).
Generation of stable cell lines expressing hLeptin-R13.2 and
hGHR–hLeptin-R13.2/12.1 fusion proteins
hLeptin-R13.2 cDNA and the sequences encoding hGHR–
hLeptin13.2 and hGHR–hLeptin12.1 were subcloned into expression
vector pRKtkNeo. The expression constructs were electroporated into
Ba/F3 cells and selected and maintained as previously described [25].
Proliferation assays 
Cells were deprived of IL-3 for 16–18 h (in RPMI 1640 supplemented
with 10 % FCS). Cells were washed in serum-free RPMI 1640 and
plated at 5 × 104 cells per well in 0.2 ml of serum-free RPMI 1640 sup-
plemented with the indicated concentration of hGH or human leptin.
Cells were stimulated for 24 h and thymidine incorporation was deter-
mined as described [25].
Antisense oligonucleotide experiments
Human CD34+ or mouse flASK cells were isolated as described above.
We synthesized antisense (AS), sense (S) and scrambled (SCR) ver-
sions of each oligonucleotide; + or – indicates the first base of the
oligonucleotide relative to the initiation methionine of the leptin receptor:
Human –20 (AS) TACTTCAGAGAAGTACAC; (S) GTGTACTTCTCT-
GAAGTA; (SCR), GAATCACGGTAACTATCA.
Human +85 (AS) CTTAAATCTCCAAGGAGT, (S) ACTCCTTGGA-
GATTTAAG; (SCR) AAGTCTTAAGCCAGACTT.
Mouse –20 (AS) TTCTTCAGAGGTGTACAC; (S) GTATACACCTCT-
GAAGAA; (SCR) ATGCGAGGCTACTTCTAT.
Mouse +84 (AS) TTAAATTTCCAGCGAGAG; (S) CTCTCCCTG-
GAAATTTAA; (SCR) ATTTGAAGGAGTTAAGCC.
CD34+ or flASK cells were incubated at a concentration of 1 × 104 per
ml in 50:50 DMEM/F12 media supplemented with 10 % FCS, L-
glutamine, and GIBCO lipid concentrate containing either sense,
antisense or scrambled oligonucleotides (70 mg ml–1). After 16 h, a
second aliquot (35 mg ml–1) of the respective oligonucleotide was
added and the cells incubated for a further 6 h.
Initially in colony assays, following incubation with the oligonucleotides,
1 × 103 CD34+ cells were incubated in complete methylcellulose
media (Stem Cell Technologies) containing 25 ng ml–1 KL, 25 ng ml–1
IL-3, and 50 ng ml–1 IL-6, EPO, G-CSF and GM-CSF. In subsequent
colony assays, following incubation with the oligonucleotides, 1 × 103
CD34+ or flASK cells were incubated in methylcellulose media contain-
ing 20 ng ml–1 IL-3, 20 ng ml–1 IL6 and 50 ng ml–1 KL. All cultures were
incubated at 37 °C for 14 d and the resulting colonies counted and
phenotyped. All assays were performed in quadruplicate.
Sub-lethal irradiation modes 
C57BLKS/J db/db, C57BLKS/Jm+/db, and C57BLKS/J+m/+m mice
were subjected to sub-lethal whole body g irradiation (750 cGy,
190 cGy min–1) as a single dose from a 137Cs source. Ten animals
were used per experimental group.
Procurement of blood samples 
Before the experiment, and at time points throughout the study, 40 ml
of blood was taken from the orbital sinus and immediately diluted into
10 ml of diluent to prevent clotting. The complete blood count from
each blood sample was measured on a Serrono Baker system 9018
blood analyzer within 60 min of collection. Only half the animals in each
dose group were bled on any given day; thus, each animal was bled on
alternate time points. Blood glucose levels were measured in orbital
sinus blood samples using One Touch glucose meters and test strips
(Johnson and Johnson).
Accession numbers 
The cDNA sequences reported in this paper have been deposited in
the GenBank database, and can be accessed using the following
numbers: U66495, U66496 and U66497.
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